Pharmaceutical Opinion Leader Management: Cultivating Today’s Influential Physicians for Tomorrow (PH109)

Pharmaceutical Opinion Leader Management includes detailed strategies for identifying, recruiting, building and maintaining thought leader relationships. The study guides opinion leader management executives with best practices for physicians in all tiers, including local, regional, national and global influencers.

Backed with real-world metrics from more than 40 companies, this study is the perfect guide for :

Setting thought leader management and MSL program budgets and headcounts

Identifying and segmenting opinion leader candidates by tier

Building thought leader relationships through new opportunities

Tracking the number of KOL relationships already established

Documenting KOL activities

Study participants included vice presidents and directors of medical affairs, product directors and managers, marketing consultants, thought leader development managers and MSL team leaders. The fair-market value benchmarks contained in this study are aggregate data collected directly from executives at participating companies.

Methodology :

Analysts developed the information upon which this study is based through both primary and secondary sources. We process for collecting and analyzing information encompasses two distinct tools: quantitative surveys and qualitative interviews. Both tools are necessary for understanding not only the hard metrics included in this study, but also the reasoning behind the metrics. We aim to answer why some companies spend more than others.

Port’s Companies, Therapeutic Areas and Interviewee Titles :

Companies

Altus Pharmaceuticals

Baxter BioScience

Bayer Healthcare Pharmaceuticals

Biogen Idec

Biolex Therapeutics

Biovail

Therapeutic Areas

Autoimmune

Cardiology and Thrombosis

CNS/Psychology

Consumer Products

Dermatology

Diabetes (Type 1)

Diabetes (Type 2)

Gastroenterology

Hematology

Infectious Diseases

Metrics Overview :

The following is a list of metrics included in Pharmaceutical Opinion Leader Management. It summarizes the main categories and types of data in the report.

Typical organizational structures

Thought leader management groups

By company size

MSL programs

Reporting relationships

Dedicated vs. non-dedicated

By company size

Average staff sizes

Thought leader management groups

Table of Contents :

From Development To Commercialization: Early-Stage Activities :

In the early stages of product development, thought leader activities are typically science-oriented, and the thought leaders will often serve as advisors to the product team. At Company 13, the business development and the new product development groups work together to develop a new product. New product development performs its own market research for potential products and calls on thought leaders to help identify true market needs. The department hosts meetings where pipeline products are discussed, and thought leaders are invited to suggest products or types of products they would like to see developed.

Tier 2 Thought Leader Profile :

While Tier 2 thought leaders do not have quite the level of recognition that Tier 1 thought leaders attain, they remain important influencers, as they carry years of clinical experience, give speeches and write for publication. Tier 2 thought leaders at surveyed companies have an average of XX years of clinical experience. They produce an average of XX publications per year and give an average of six promotional speeches per year.

for more information, please visit our web site :

http://www.bharatbook.com/detail.asp?id=71140